rs281865161

Variant summary

Our verdict is Pathogenic. The variant received 14 ACMG points: 14P and 0B. PS3PM1PP5_Very_Strong

The NM_000484.4(APP):​c.2010_2011delGAinsTC​(p.LysMet670AsnLeu) variant causes a missense change. The variant was absent in control chromosomes in GnomAD project. It is difficult to determine the true allele frequency of this variant because it is of type MNV, and the frequency of such variant types in population databases may be underestimated and unreliable. Variant has been reported in ClinVar as Pathogenic (★★). ClinVar reports functional evidence for this variant: "SCV000951935: Experimental studies have shown that this sequence change disrupts protein function in vivo and in vitro (PMID:8810256, 21335619, 23649480)." and additional evidence is available in ClinVar. Synonymous variant affecting the same amino acid position (i.e. K670K) has been classified as Likely benign.

Frequency

Genomes: not found (cov: 32)

Consequence

APP
NM_000484.4 missense

Scores

Not classified

Clinical Significance

Pathogenic criteria provided, multiple submitters, no conflicts P:4O:2

Conservation

PhyloP100: 6.73

Publications

3 publications found
Variant links:
Genes affected
APP (HGNC:620): (amyloid beta precursor protein) This gene encodes a cell surface receptor and transmembrane precursor protein that is cleaved by secretases to form a number of peptides. Some of these peptides are secreted and can bind to the acetyltransferase complex APBB1/TIP60 to promote transcriptional activation, while others form the protein basis of the amyloid plaques found in the brains of patients with Alzheimer disease. In addition, two of the peptides are antimicrobial peptides, having been shown to have bacteriocidal and antifungal activities. Mutations in this gene have been implicated in autosomal dominant Alzheimer disease and cerebroarterial amyloidosis (cerebral amyloid angiopathy). Multiple transcript variants encoding several different isoforms have been found for this gene. [provided by RefSeq, Aug 2014]
APP Gene-Disease associations (from GenCC):
  • cerebral amyloid angiopathy, APP-related
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp, ClinGen
  • Alzheimer disease type 1
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp
  • ABeta amyloidosis, Arctic type
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • ABeta amyloidosis, dutch type
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • ABeta amyloidosis, Iowa type
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • ABeta amyloidosis, Italian type
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • ABetaA21G amyloidosis
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • ABetaL34V amyloidosis
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • early-onset autosomal dominant Alzheimer disease
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_000484.4, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Pathogenic. The variant received 14 ACMG points.

PS3
PS3 evidence extracted from ClinVar submissions: SCV000951935: Experimental studies have shown that this sequence change disrupts protein function in vivo and in vitro (PMID: 8810256, 21335619, 23649480).; SCV004804178: Several publications reported experimental evidence evaluating an impact on protein function, and demonstrated that the variant causes ~5-10-fold increase in the production of the amyloidogenic C-terminal peptide fragments (e.g. Felsenstein_1992), and results in pathological features reminiscent of Alzheimer Disease pathology in transgenic mice (e.g. Sturchler-Pierrat_1997). PMID: 1302033, 21335619, 28209190 , 36626935, 8012386, 9371838; SCV004112130: Several transgenic mouse models demonstrate this variant, often referred to as the Swedish mutant, having a negative effect on APP function (Aso et al. 2012. PubMed ID: 22188425; Cuddy et al. 2015. PubMed ID: 25970623; Felsenstein et al. 1994. PubMed ID: 8012386; Sturchler-Pierrat C et al. 1997. PubMed ID: 9371838; Katsurabayashi et al. 2016. PubMed ID: 26733247; Munter et al. 2010. PubMed ID: 20452985; Rabe et al. 2011. PubMed ID: 21812781; Rodrigues et al. 2012. PubMed ID: 22843498).
PM1
In a hotspot region, there are 3 aminoacids with missense pathogenic changes in the window of +-8 aminoacids around while only 2 benign, 7 uncertain in NM_000484.4
PP5
Variant 21-25897626-TC-GA is Pathogenic according to our data. Variant chr21-25897626-TC-GA is described in ClinVar as Pathogenic. ClinVar VariationId is 18093.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000484.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
APP
NM_000484.4
MANE Select
c.2010_2011delGAinsTCp.LysMet670AsnLeu
missense
N/ANP_000475.1P05067-1
APP
NM_001204301.2
c.1956_1957delGAinsTCp.LysMet652AsnLeu
missense
N/ANP_001191230.1P05067-9
APP
NM_201413.3
c.1953_1954delGAinsTCp.LysMet651AsnLeu
missense
N/ANP_958816.1P05067-8

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
APP
ENST00000346798.8
TSL:1 MANE Select
c.2010_2011delGAinsTCp.LysMet670AsnLeu
missense
N/AENSP00000284981.4P05067-1
APP
ENST00000357903.7
TSL:1
c.1953_1954delGAinsTCp.LysMet651AsnLeu
missense
N/AENSP00000350578.3P05067-8
APP
ENST00000439274.6
TSL:1
c.1842_1843delGAinsTCp.LysMet614AsnLeu
missense
N/AENSP00000398879.2E9PG40

Frequencies

GnomAD3 genomes
Cov.:
32
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
Cov.:
32

ClinVar

ClinVar submissions
Significance:Pathogenic
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
2
-
-
Alzheimer disease (3)
1
-
-
Alzheimer disease type 1 (1)
1
-
-
APP-related disorder (1)
-
-
-
not provided (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
PhyloP100
6.7
Mutation Taster
=0/200
disease causing

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs281865161;
hg19: chr21-27269938;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.